Research Journal of Topical and Cosmetic Sciences

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Formulation, Development and Evaluation of Film-Forming Gel for Prolonged Dermal Delivery of Miconaole Nitrate


Affiliations
1 Department of Pharmaceutical Chemistry, KCT’S R.G. Sapkal College of Pharmacy, Anjaneri, Nasik 422 213, Maharashtra, India
2 Department of Quality Assurance and Techniques, KCT’s R.G. Sapkal College of Pharmacy, Anjaneri, Tal. Trimbakeshwar, Dist. Nashik-422213, Maharashtra, India
     

   Subscribe/Renew Journal


The localized treatment of diseases of body tissues requires that the pharmaceutical active be maintained at the site of treatment for an effective period of time. Sweat, clothing, movements and getting washed away easily on contact with water are some of the problems that have limited the effectiveness and residence time of conventional topical formulations for treatment of fungal infections of skin. This necessitates longer treatment duration. Hence, a composition that adheres to skin surface afflicted and provides localized delivery of an antifungal agent is needed. The present work aims at designing a dosage form of Miconazole nitrate referred to as a ‘film-forming gel’ which on application forms a thin, transparent film on skin surface. Eudragit RS PO and hydroxypropyl cellulose were used in combination to provide a matrix film that would permit the release of the antifungal agent for a prolonged time. The formulations were prepared using 32 full factorial design. They were tested for drying time, drug release, antifungal activity, skin irritation and stability studies. The gel was characterised for pH, viscosity, drug content, effective dosage volume and mechanical properties of the film formed after application; water vapour permeability were also tested. All the formulations showed results within acceptable range for various tests. The optimized formulation showed drug release of 99.76% and antifungal activity in terms of efficacy as 98.78%. Such a formulation can be claimed to decrease duration of therapy, will be more accepted by the patients and be a breakthrough in treating fungal infections of the skin.

Keywords

Miconazole Nitrate; Fungal Skin Infections, Film-Forming Gel, Eudragit RS PO, Hydroxypropyl Cellulose.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Langer R. Transdermal drug delivery, Advance Drug Delivery Reviews 2004; 56: 557-558.

  • C.C Long, Common Skin Disorders and their Topical Treatment. In: Walters KA, editor. Dermatological and Transdermal Formulations. New York: Marcel Dekker Inc., 2002, p. 1-12, 53-54. (Drugs and the Pharmaceutical Sciences, vol 119).

  • Afaf A. Ramadan: Formulation and evaluation of bioadhesive gels containing Miconazole Nitrate. Journal of Applied Sciences Research 2008; 4(9).1052-1065.

  • C.B. Moore, C.M. Walls, D.W. Denning, In vitro activities of terbinafine against Aspergillus species in comparison with those of itraconazole and amphotericin B, Antimicrobial Agents and Chemotherapy, 2001, 45(6):1882-85.

  • S. Gungor, M.S. Erdal, B. Aksu, New formulation strategies in topical antifungal therapy. Journal of Cosmetics, Dermatological Sciences and Applications, 2013, 3:56-65.

  • H. Vaghasiya, A. Kumar, K. Sawant, Development of solid lipid nanoparticles based controlled release system for topical delivery of terbinafine hydrochloride, European Journal of Pharmaceutics and Biopharmaceutics, 2013, 49:311-22.

  • M. Sen, A. Yakar, Controlled release of antifungal drug terbinafine hydrochloride from poly(N-vinyl 2-pyrrolidone /itaconic acid)hydrogels, International Journal of Pharmaceutics, 2001, 228:33-41.

  • D.J. Lunter, R. Daniels, New film forming emulsions containing Eudragit NE and/or RS 30D for sustained dermal delivery of nonivamide, European Journal of Pharmaceutics and Biopharmaceutics, 2012, 82:291-98.

  • I.Z. Schroeder, P. Franke, U.F. Schaefer, C.M. Lehr, Development and characterization of film forming polymeric solutions for skin drug delivery, European Journal of Pharmaceutics and Biopharmaceutics, 2007, 65:111-21.

  • Li X, R. Zhang, R. Liang, W. Liua, C. Wanga, Z. Su, F. Sun, Y. Li, Preparation and characterization of sustained-release rotigotine film-forming gel, International Journal of Pharmaceutics, 2014, 460(1):273-79.

  • GELNIQUE [package insert]. Morristown, NJ: Watson Pharmaceuticals, Inc., 2008.

  • BeeGentle [package insert]. West Jordan, UT: CAO Group, Inc., 2010.

  • J.L. Zatz, G.P. Kushla, Gels In: H.A. Lieberman, M.M. Rieger, G.S. Banker, editors. Pharmaceutical Dosage Forms-Disperse System. 2nd ed. New York: Marcel Dekker Inc. p.399-405. (Drugs and the Pharmaceutical Sciences, vol 2).

  • K. Saroha, S. Singh, A. Aggarwal, S. Nanda, Transdermal Gels- An alternative vehicle for drug delivery, International Journal of Pharmaceutical, Chemical and Biological Sciences 2013, 3(3):495-03.

  • M.A. Attia, H.Y. Badawy, Film forming gel for treatment of oral mucositis: In vitro studies, International Journal of Drug Delivery, 2010, 2:314-321.

  • R. Guo , Du X., Zhang R., Deng L., Dong A., Zhang J., Bioadhesive film formed from a novel organic–inorganic hybrid gel for transdermal drug delivery system, European Journal of Pharmaceutics and Biopharmaceutics, 2011, 79:574-83.

  • L.K. Souza, C.H. Bruno, L. Lopes, S.H. Pulcinelli, C.V. Santilli, L.A. Chiavacci, Ureasil–polyether hybrid filmforming materials, Colloids and Surfaces B: Biointerfaces, 2013, 101:156-61.

  • D.M. Jayes, B.S. Nitzan, M.R. Royz, D.M. Barak, O.B. Sholto, R. Zion, S.R. Daudy, inventors, Petah Tikva, assignee, Terbinafine Formulation, US patent2010/0168233 A1. 2010 July 1.

  • S.M. Mohamed, A.M.E. Masoud, M.D. Elgadir, M.A. Mahdy, Preparation and release charcteristics of itraconazole polymeric films for topical application, International Journal of Pharmacy and Pharmaceutical Sciences, 2013, 5(3):167-70.

  • B.K. Dey, P.K. Kar, L.K. Nath, Formulation, design, preparation and in vitro-in vivo evaluation of propranolol hydrochloride transdermal patches using hydrophilic and hydrophobic polymer complex, Research Journal of Pharmacy and Technology, 2009, 2(1):155-60.

  • Y.B. Ubarchande, T. Regupathy, C. Vijaya, S.V. Deshmane, Formulation and evaluation of mucoadhesive buccal films of losartan potassium, Research Journal of Pharmacy and Technology, 2009, 2(4):833-36.

  • C. Suja, C. Ramasamy, R. Narayanacharyula, Development and evaluation of lisinopril transdermal patches, Research Journal of Pharmacy and Technology. 2011, 4(8):1260-64.

  • S.V. Kulkarni, R.P. Kumar, N. Patel, R.B. Someshwara, A.P. Kumar, Development and evaluation of diltiazem HCl transdermal patches by using glycerol and castor oil as plasticizers, Research Journal of Pharmacy and Technology, 2010, 3(3):905-09.

  • J.R. Kumar, S. Muralidharan, S.A. Dhanaraj, Formulation and in-vitro evaluation of terbinafine hydrochloride transdermal patches, Journal of Pharmaceutical Sciences and Research, 2012, 4(6):1840-43.

  • D.K. Jain, G.N. Darwhekar, S. Chaurasia, Formulation development and evaluation of transdermal patches of losartan, International Journal of Pharmtech Research, 2012, 4(2):757-64.

  • D.S. Kumar, R. Sairam, S. Anandbabu, L. Karpagavalli, A. Maheswaran, N. Narayanan, Formulation and evaluation of transdermal patches of salbutamol, Research Journal of Pharmaceutical, Biological and Chemical Sciences, 2012, 3(3):1132-38.

  • P. Verma, K. Pathak, Nanosized ethanolic vesicles loaded with econazole nitrate for the treatment of deep fungal infections through topical gel formulation, Nanomedicine: Nanotechnology, Biology, and Medicine, 2012, 8:489-96.

  • S. Amin, S.R. Mir, K. Kohli, A. Ali, Novel polymeric matrix films for transdermal delivery of metoclopramide, International Journal of Pharmaceutical Frontier Research, 2012, 2(1):48-60.

  • R. Vijaya, S. Sureshkumar, S. Umamaheswari, M. Prakash, T. Senbagapriya, A. Umamaheswari, Preparation of amitriptyline hydrochloride films using eudragit RL 100 and hydroxypropyl methyl cellulose polymers and their in vitro evaluation for effective transdermal delivery, International Journal of Life Science and Pharma Research, 2012, 2(2):7-15.

  • M. Bharkatiya, R.K. Nema, M. Bhatnagar, Designing and characterization of drug free patches for transdermal application, International Journal of Pharmaceutical Sciences and Drug Research, 2010, 2(1):35-39.

  • R. Khullar, D. Kumar, N. Seth, S. Saini, Formulation and evaluation of mefenamic acid emulgel for topical delivery, Saudi Pharmaceutical Journal, 2012, 20:63-67.

  • W. Zhua, C. Guoa, A. Yua, Y. Gaoa, F. Caoa, G. Zhai, Microemulsion-based hydrogel formulation of penciclovir for topical delivery, International Journal of Pharmaceutics, 2009, 378:152-58.

  • International Conference on Harmonization Steering Committee, ICH Harmonized Tripartite Guideline-Stability Testing of New Drug Substances and Products, ICH Q1A (R2), February 6, 2003.

  • P.A. McCarron, R.F. Donnelly, A. Zawislak, A.D. Woolfson, Design and evaluation of a water-soluble bioadhesive patch formulation for cutaneous delivery of 5-aminolevulinic acid to superficial neoplastic lesions, European Journal of Pharmaceutical Sciences, 2006, 27:268-79.

  • D.M. Jayes, B.S. Nitzan, M.R. Royz, D.M. Barak, O.B. Sholto, R. Zion, S.R. Daudy, inventors, Petah Tikva, assignee, Terbinafine Formulation, US patent2010/0168233 A1. 2010 July 1.

  • P.D. Sawant, D. Luu, R. Ye, R. Buchta, Drug release from hydroethanolic gels, Effect of drug’s lipophilicity (log P), polymer–drug interactionns and solvent lipophilicity, International Journal of Pharmaceutics, 2010, 396:45-52.

  • H.K. Doddamani, Formulation and validation of organogels as carriers for topical delivery of Terbinafine hydrochloride [dissertation], Bengaluru, India: Ragiv Gandhi University, 2012.

  • I. Weuts, D. Kempen, A. Decorte, G. Verreck, J. Peeters, M. Brewster, G.V. Mooter, Physical stability of the amorphous state of loperamide and two fragment molecules in solid dispersions with the polymers PVP-K30 and PVP-VA64, European Journal of Pharmaceutical Sciences, 2005, 25:313-20.


Abstract Views: 442

PDF Views: 1




  • Formulation, Development and Evaluation of Film-Forming Gel for Prolonged Dermal Delivery of Miconaole Nitrate

Abstract Views: 442  |  PDF Views: 1

Authors

R. B. Saudagar
Department of Pharmaceutical Chemistry, KCT’S R.G. Sapkal College of Pharmacy, Anjaneri, Nasik 422 213, Maharashtra, India
P. A. Gangurde
Department of Quality Assurance and Techniques, KCT’s R.G. Sapkal College of Pharmacy, Anjaneri, Tal. Trimbakeshwar, Dist. Nashik-422213, Maharashtra, India

Abstract


The localized treatment of diseases of body tissues requires that the pharmaceutical active be maintained at the site of treatment for an effective period of time. Sweat, clothing, movements and getting washed away easily on contact with water are some of the problems that have limited the effectiveness and residence time of conventional topical formulations for treatment of fungal infections of skin. This necessitates longer treatment duration. Hence, a composition that adheres to skin surface afflicted and provides localized delivery of an antifungal agent is needed. The present work aims at designing a dosage form of Miconazole nitrate referred to as a ‘film-forming gel’ which on application forms a thin, transparent film on skin surface. Eudragit RS PO and hydroxypropyl cellulose were used in combination to provide a matrix film that would permit the release of the antifungal agent for a prolonged time. The formulations were prepared using 32 full factorial design. They were tested for drying time, drug release, antifungal activity, skin irritation and stability studies. The gel was characterised for pH, viscosity, drug content, effective dosage volume and mechanical properties of the film formed after application; water vapour permeability were also tested. All the formulations showed results within acceptable range for various tests. The optimized formulation showed drug release of 99.76% and antifungal activity in terms of efficacy as 98.78%. Such a formulation can be claimed to decrease duration of therapy, will be more accepted by the patients and be a breakthrough in treating fungal infections of the skin.

Keywords


Miconazole Nitrate; Fungal Skin Infections, Film-Forming Gel, Eudragit RS PO, Hydroxypropyl Cellulose.

References